Current state of renal transplant immunosuppression: Present and future

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines for Clinical Practice

World J Transplant. Aug 24, 2012; 2(4): 51-68
Published online Aug 24, 2012. doi: 10.5500/wjt.v2.i4.51

Table 4 Comparative adverse effects of prolonged release Tacrolimus and Tacrolimus (%)

ADR	Prolonged released Tacrolimus	Tacrolimus twice daily
Gastrointestinal
Diarrhea	45.3	44.3
Loose stools	5.1	7.1
Metabolism and nutritional
Hyperlipidemia	16.4	17.5
Diabetes mellitus	14.0	11.3
Hyponatremia	2.8	0.9
Infections and infestations
Sinusitis	7.0	3.3
Gastroenteritis	6.5	0.5
Peripheral edema	35.5	34.9
Nervous system
Tremor	35.0	34.4
Paraesthesia	5.6	1.4
Vascular
Orthostatasis	7.0	4.7
Lymphocele	0.5	0.9
Psychiatric
Insomnia	25.7	30.2
Skin
Alopecia	6.5	7.1

Citation: Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012; 2(4): 51-68
URL: https://www.wjgnet.com/2220-3230/full/v2/i4/51.htm
DOI: https://dx.doi.org/10.5500/wjt.v2.i4.51

Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012; 2(4): 51-68 [PMID: 24175197 DOI: 10.5500/wjt.v2.i4.51]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.